GAFFX
Price
$77.91
Change
-$0.26 (-0.33%)
Updated
Jun 5 closing price
Net Assets
304.87B
WMKGX
Price
$22.49
Change
-$0.10 (-0.44%)
Updated
Jun 5 closing price
Net Assets
322.73M
Interact to see
Advertisement

GAFFX vs WMKGX

Header iconGAFFX vs WMKGX Comparison
Open Charts GAFFX vs WMKGXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.91
Change-$0.26 (-0.33%)
VolumeN/A
Net Assets304.87B
WesMark Large Company Fund
Price$22.49
Change-$0.10 (-0.44%)
VolumeN/A
Net Assets322.73M
GAFFX vs WMKGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. WMKGX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and WMKGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 305B vs. WMKGX (323M). GAFFX pays higher dividends than WMKGX: GAFFX (0.65) vs WMKGX (0.06). GAFFX was incepted earlier than WMKGX: GAFFX (8 years) vs WMKGX (28 years). WMKGX (1.16) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. WMKGX (16.00). WMKGX has a lower initial minimum investment than GAFFX: WMKGX (1000) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 9.03 vs. WMKGX (-3.60). GAFFX return over 5 years is better than : 46.12 vs. WMKGX (11.94).
GAFFXWMKGXGAFFX / WMKGX
Total Expense Ratio0.301.1626%
Annual Report Gross Expense Ratio0.301.1626%
Fund Existence8 years28 years-
Gain YTD4.968-1.707-291%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets305B323M94,427%
Annual Yield % from dividends0.650.061,017%
Returns for 1 year9.03-3.60-251%
Returns for 3 years38.86-0.14-28,785%
Returns for 5 years46.1211.94386%
Returns for 10 yearsN/A17.82-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMDYX34.88N/A
N/A
Hartford MidCap Y
NCLEX29.01N/A
N/A
Nicholas Limited Edition I
FIJYX28.64N/A
N/A
Fidelity Advisor Biotechnology Z
FWOZX17.16N/A
N/A
Fidelity Advisor Women's Leadership Z
EEMGX8.71N/A
N/A
MFS Emerging Markets Equity Research R4